跳至主要内容
临床试验/NCT05637931
NCT05637931尚未招募不适用

Evaluation of Circulating PlexinD1 as a Potential Biomarker of Polymyositis and Dermatomyositis.

Assiut University0 个研究点目标入组 66 人开始时间: 2022年12月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
66
主要终点
Evaluation of circulating PlexinD1 as a potential biomarker of polymyositis and dermatomyositis.

研究概览

简要总结

evaluation of level of serum circulating plexin D1 on extacellular vesicles in adult PM/DM patients and juvenile dermatomysitis.

详细描述

Polymyositis (PM) and dermatomyositis (DM) are autoimmune inflammatory diseases that primarily target muscle.

autoimmune Dermatomyositis (DM) is a rare inflammatory disease that mainly affects skin, muscle, and lung.

Inflammatory myopathies (IMs) often have distinct histopathologic features suggesting humorally mediated involvement of the microcirculation in dermatomyositis (DM), including early capillary deposition of the complement C5b-9 membranolytic attack complex (MAC) and secondary ischaemic changes; and CD8 T-cell-mediated and MHC1-restricted autoimmune attack of myofibers in polymyositis (PM) and inclusion body myositis.

Plexins are a conserved family of large proteins (~200kDa) that are the canonical receptors for semaphorin molecules. Plexins are divided into four classes, A through D.

Recently, plexin and semaphorin molecules have been shown to control cell movement and cell-cell interaction in the immune system .

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Adult PM/DM patients .
  • Juvenile dermatomyositis patients.

排除标准

  • 1-Patients with other autoimmune diseases ( rheumatoid arthritis ,systemic lupus erythematosus, polyarteritis nodosa sarcoidosis, scleroderma, spondylarthritis and inflammatory bowel disease) 2-Patients with malignant tumors 3-Patients with active infection 4-Patients with severe heart, lung, and kidney dysfunction

结局指标

主要结局

Evaluation of circulating PlexinD1 as a potential biomarker of polymyositis and dermatomyositis.

时间窗: baseline

evaluation of plexinD1in PM/DM patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reham Khalifa Ali Khalifa

doctor

Assiut University

相似试验